MEDREV (pharmacy-health psychology intervention in people living with dementia with behaviour that challenges): the feasibility of measuring clinical outcomes and costs of the intervention

Table 2 Mean NPI total scores at each time point for participants whose medication changed vs. those where medication remained the same

	Baseline −2	Baseline −1	Baseline T0	8 week follow-up	3 month follow-up	6 month follow-up
Participants with a medication change
Number of participants	n = 5	n = 11	n = 12	n = 11	n = 10	n = 5
Mean score (SD)	34.8 (30.5)	18.4 (19.7)	17.4 (13.9)	23.6 (22.6)	18.3 (12.3)	10.4 (8.4)
Range	10 to 70	0 to 71	0 to 51	0 to 77	0 to 33	0 to 18
Participants with no medication change
Number of participants	n = 0	n = 0	n = 17	n = 13	n = 7	n = 4
Mean score (SD)	N/A	N/A	22.3 (24.0)	23.5 (28.7)	45.1 (32.0)	56.3 (39.7)
Range	N/A	N/A	0 to 83	0 to 59	22 to 120	0 to 114

Note: T0 is the baseline common to all participants, who received the medication review. Baseline −1 and − 2 refer to any previous baselining

ISSN: 1472-6963